EP33: Redefining Obesity, WHO’s New Stance, GLP-1s and the Future of Obesity Care

Obesity is now officially defined by the WHO as a chronic, relapsing disease, not just a lack of willpower. In 2025, the WHO released new guidelines incorporating GLP-1 therapies into treatment recommendations. This article dives into how this breakthrough is reshaping global health and what it means for you. Reference: Celletti, F., Farrar, J., & De Regil, L. (2025). World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults. JAMA. -- Hosting provided by SoundOn